Corient Capital Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.23M Buy
2,637
+151
+6% +$73.5K 0.09% 181
2022
Q2
$1.16M Buy
2,486
+124
+5% +$55.2K 0.09% 195
2022
Q1
$1.03M Buy
2,362
+264
+13% +$110K 0.07% 243
2021
Q4
$973K Buy
2,098
+70
+3% +$31K 0.06% 230
2021
Q3
$789K Sell
2,028
-172
-8% -$73K 0.06% 257
2021
Q2
$974K Buy
2,200
+152
+7% +$66.4K 0.07% 218
2021
Q1
$859K Buy
2,048
+121
+6% +$48.3K 0.07% 216
2020
Q4
$790K Sell
1,927
-49
-2% -$20.4K 0.08% 204
2020
Q3
$818K Sell
1,976
-58
-3% -$23.3K 0.09% 187
2020
Q2
$789K Buy
2,034
+87
+4% +$32.6K 0.1% 191
2020
Q1
$611K Buy
1,947
+367
+23% +$124K 0.1% 184
2019
Q4
$579K Buy
1,580
+55
+4% +$17.4K 0.07% 258
2019
Q3
$390K Buy
1,525
+349
+30% +$97.8K 0.06% 304
2019
Q2
$312K Buy
1,176
+221
+23% +$56K 0.05% 298
2019
Q1
$254K Buy
+955
New +$275K 0.04% 306

Other funds holding HUM

Corient Capital Partners's HUM Position: Q3 2022 in Review

Corient Capital Partners increased its Humana (HUM) stake by 6.1% in Q3 2022, buying an estimated $73.5K and bringing the position to 2,637 shares worth $1.23M. The position accounts for 0.09% of the portfolio, ranked #181.

Corient Capital Partners first reported a position in HUM in Q1 2019 and has held it in 15 quarters since. 1,000 funds tracked by Wall St. Rank hold HUM as of Q3 2022.

  • Corient Capital Partners held 2,637 shares of Humana worth $1.23M as of Q3 2022.
  • Corient Capital Partners bought 151 Humana shares in Q3 2022, an estimated $73.5K.
  • Humana made up 0.09% of Corient Capital Partners's portfolio in Q3 2022, its #181 holding.
  • Corient Capital Partners first reported a position in Humana in Q1 2019 and has held it in 15 quarters since.
  • 1,000 funds tracked by Wall St. Rank held Humana as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.